Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Dizziness with a pulse under 50 while taking diltiazem can be a sign that the medication is slowing your heart rate too much, and it deserves prompt attention rather than a wait and see approach. Mild, occasional lightheadedness is common when starting or increasing the dose, but a sustained heart rate below 50 paired with fainting, near fainting, chest discomfort, shortness of breath, confusion, or extreme fatigue may signal symptomatic bradycardia or heart block and warrants urgent medical care. Risk rises if you also take beta blockers, digoxin, or other rate slowing drugs, if you are older, or if you have existing conduction problems or kidney or liver impairment. Never stop diltiazem abruptly on your own, since rebound effects can raise blood pressure or trigger angina, and several other factors are worth weighing before you act, as explained below.
Because the line between an expected side effect and a dangerous one depends on your numbers, your other medications, and how you feel, a few minutes of structured self assessment can help you decide whether to call your prescriber today or seek emergency care now. Take a free, instant, online symptom check to clarify what your symptoms may mean and get guidance on the right next step.
Last reviewed for medical accuracy: 09/17/2026
Diltiazem is a medication commonly prescribed to treat high blood pressure, chest pain (angina), and certain heart rhythm problems. As a non-dihydropyridine calcium channel blocker, it works by relaxing blood vessels, reducing heart workload, and slowing electrical conduction through the atrioventricular (AV) node. While many people tolerate diltiazem well, some experience side effects—most notably dizziness or a slower heart rate (bradycardia).
This guide will help you understand why these effects occur, when they become dangerous, and what steps you can take if you notice troubling symptoms.
Blood Vessel Relaxation
Diltiazem dilates (widens) arteries, which lowers blood pressure. A sudden drop in pressure can lead to reduced blood flow to the brain, causing lightheadedness or dizziness.
Slowed Heart Rate
By inhibiting calcium entry into AV node cells, diltiazem slows electrical conduction. This decreases your heart rate (negative chronotropy). If the pulse dips below 50 beats per minute (bpm), you may feel weak, fatigued, or dizzy.
Reduced Heart Contractility
Diltiazem decreases the force of heart muscle contraction (negative inotropy), which can further lower blood pressure and contribute to symptoms of low perfusion (e.g., dizziness).
According to clinical studies and prescribing information:
Most side effects are mild to moderate and improve over time or with dose adjustment.
Not all dizziness or slow pulse readings are cause for immediate alarm. However, certain signs suggest a more serious issue:
Severe or Persistent Dizziness
– You feel faint or unsteady with every change in position.
– You experience near-syncope (a sense that you might pass out).
Pulse Below 50 bpm with Symptoms
– Heart rate remains under 50 bpm alongside weakness, chest discomfort, or confusion.
– You notice skipped beats, pounding, or fluttering sensations.
Low Blood Pressure-Related Signs
– Systolic blood pressure below 90 mm Hg with dizziness.
– Cold, clammy skin or excessive sweating.
Additional Concerning Symptoms
– Shortness of breath at rest.
– Chest pain or pressure.
– Sudden vision changes or severe headache.
– Fainting (syncope).
If you experience any of these, stop activities that put you at risk of falling (e.g., climbing ladders, driving) and seek medical help promptly.
If your dizziness or slow pulse is mild, here are practical steps:
Even mild symptoms deserve attention if they persist or worsen. Reach out to your doctor or nurse if you notice:
Your provider may:
If you’re unsure how urgent your symptoms are, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you sort through possible causes and advise whether to seek immediate care or schedule a routine appointment.
free, online symptom check, using the doctor approved Ubie Symptom Checker
To reduce the risk of troublesome side effects from diltiazem:
Remember: This information is educational and does not replace medical advice. If you experience life-threatening or serious symptoms, call emergency services or go to your nearest emergency department immediately. For any concerns about diltiazem or your heart health, speak to a doctor.
(References)
* Siegel JD, Ko CJ. Diltiazem-associated Photodistributed Hyperpigmentation. Yale J Biol Med. 2020 Mar;93(1):45-47. Epub 2020 Mar 27. PMID: 32226335; PMCID: PMC7087047.
* Graudins A, Lee HM, Druda D. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Br J Clin Pharmacol. 2016 Mar;81(3):453-61. doi: 10.1111/bcp.12763. Epub 2015 Oct 30. PMID: 26344579; PMCID: PMC4767195.
* Calcium Channel Blockers. 2012. PMID: 31643892.
* Andrusaitis JG, Givertz A. Calcium Channel Blocker Overdose. J Educ Teach Emerg Med. 2024 Jan;9(1):O1-O25. doi: 10.21980/J8CQ07. Epub 2024 Jan 31. PMID: 38344049; PMCID: PMC10854886.
* Aronow WS. Atrial fibrillation. Heart Dis. 2002 Mar-Apr;4(2):91-101. doi: 10.1097/00132580-200203000-00006. PMID: 11975840.
* Scheinman MM, Hess DS. New antiarrhythmic drugs. Am J Surg. 1983 Jun;145(6):724-32. doi: 10.1016/0002-9610(83)90129-0. PMID: 6407348.
* Wu Y, Peng FH, Gao X, Yan XX, Zhang F, Tan JS, Hu S, Hua L. Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension. Front Cardiovasc Med. 2022;9:918735. doi: 10.3389/fcvm.2022.918735. Epub 2022 Sep 7. PMID: 36158824; PMCID: PMC9489906.
* Pil E, Levy M, Chizmar T, Troncoso R, Garfinkel E, Margolis A. Efficacy and Safety of Prehospital Diltiazem. Prehosp Emerg Care. 2024;28(7):920-927. doi: 10.1080/10903127.2024.2326598. Epub 2024 Mar 14. PMID: 38436598.
* Altunbas G, Ercan S, Sucu M, Davutoglu V. Atrial Fibrillation Triggered By Drug-Induced Bradycardia. J Atr Fibrillation. 2016 Oct-Nov;9(3):1428. doi: 10.4022/jafib.1428. Epub 2016 Oct 31. PMID: 28496924; PMCID: PMC5368544.
* Choong CL, Wong HS, Lee FY, Lee CK, Kho JV, Lai YX, Vikneswaran T. Dose-Response Relationship Between Diltiazem and Tacrolimus and Its Safety in Renal Transplant Recipients. Transplant Proc. 2018 Oct;50(8):2515-2520. doi: 10.1016/j.transproceed.2018.04.024. Epub 2018 Apr 12. PMID: 30316389.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.